GLAUKOS ($GKOS) posted quarterly earnings results on Wednesday, April 30th. The company reported earnings of -$0.22 per share, beating estimates of -$0.35 by $0.13. The company also reported revenue of $106,660,000, beating estimates of $104,555,028 by $2,104,972.
You can see Quiver Quantitative's $GKOS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GLAUKOS Insider Trading Activity
GLAUKOS insiders have traded $GKOS stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $GKOS stock by insiders over the last 6 months:
- MARK J FOLEY sold 20,687 shares for an estimated $2,497,334
- GILBERT H KLIMAN has made 0 purchases and 2 sales selling 12,000 shares for an estimated $1,790,820.
- JOSEPH E GILLIAM (PRESIDENT & COO) has made 0 purchases and 3 sales selling 5,603 shares for an estimated $814,872.
- TOMAS NAVRATIL (CHIEF DEVELOPMENT OFFICER) sold 3,416 shares for an estimated $502,630
- ALEX R. THURMAN (SVP & CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 1,520 shares for an estimated $162,398.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GLAUKOS Hedge Fund Activity
We have seen 154 institutional investors add shares of GLAUKOS stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 833,292 shares (+231.8%) to their portfolio in Q4 2024, for an estimated $124,943,802
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 809,589 shares (+inf%) to their portfolio in Q4 2024, for an estimated $121,389,774
- WESTFIELD CAPITAL MANAGEMENT CO LP added 804,614 shares (+31715.2%) to their portfolio in Q4 2024, for an estimated $120,643,823
- ALLIANCEBERNSTEIN L.P. added 755,035 shares (+1235.4%) to their portfolio in Q4 2024, for an estimated $113,209,947
- 1832 ASSET MANAGEMENT L.P. added 689,500 shares (+2039.9%) to their portfolio in Q4 2024, for an estimated $103,383,630
- FMR LLC removed 472,732 shares (-7.2%) from their portfolio in Q4 2024, for an estimated $70,881,436
- RTW INVESTMENTS, LP removed 386,291 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $57,920,472
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GLAUKOS Government Contracts
We have seen $586,040 of award payments to $GKOS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IDOSE TR 75CMG IMPLANT: $234,416
- IDOSE TRAVOPROST 75MCG IMPLANT: $213,105
- IDOSE TR 75MCG IMPLANT TRADE: $21,310
- PROS IMPLANTS: $21,310
- PROS IMPLANT: $21,310
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
GLAUKOS Analyst Ratings
Wall Street analysts have issued reports on $GKOS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/03/2025
- Citigroup issued a "Buy" rating on 12/11/2024
- Morgan Stanley issued a "Underweight" rating on 12/02/2024
To track analyst ratings and price targets for GLAUKOS, check out Quiver Quantitative's $GKOS forecast page.
GLAUKOS Price Targets
Multiple analysts have issued price targets for $GKOS recently. We have seen 5 analysts offer price targets for $GKOS in the last 6 months, with a median target of $149.0.
Here are some recent targets:
- Thomas Stephan from Stifel Nicolaus set a target price of $175.0 on 12/31/2024
- Richard Newitter from Truist Financial set a target price of $185.0 on 12/18/2024
- Patrick Wood from Morgan Stanley set a target price of $120.0 on 12/02/2024
- David Saxon from Needham set a target price of $149.0 on 11/05/2024
- Ryan Zimmerman from BTIG set a target price of $140.0 on 11/05/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
